(Date:2/8/2010)... surface for label-free biomolecular interaction analysis now offers surface ... Protein A and Protein G for coupling antibodies. ... ... CA (PRWEB) February 8, 2010 -- Silicon Kinetics Inc., ... the world,s first 3D biosensor surface for label-free biomolecular ...
(Date:2/8/2010)... and NEW ORLEANS , Feb. 8 ... a worldwide developer and marketer of diagnostic test kits, ... extension of the collaborative effort to combat viral hemorrhagic ... $800,000 in contract revenue for Corgenix over ... Institutes of Health (NIH) has awarded a five-year contract ...
(Date:2/8/2010)... the ClearTrial clinical services team to present the critical processes ... clinical development departments. , ... Chicago, ... of Clinical Trial Operations (CTO) software, today announced that both ... have been selected to speak at the CBI Forecasting & ...
(Date:2/8/2010)... , Feb. 8 /PRNewswire-Asia-FirstCall/ -- ... "the Company"), a leading China -based ... marketing,biopharmaceutical products, today announced a collaboration and ... and commercialize its,Nephoxil(R) pharmaceutical product for the ... Nephoxil (ferric citrate) ...
Breaking Biology Technology:Silicon Kinetics Announces New Biosensor Chips With Wide Palette of Surface Chemistries 2Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents 2Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents 3Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents 4Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents 5Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents 6Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents 7ClearTrial Selected to Provide Methodologies for Accurately Forecasting and Budgeting Clinical Spend and Integrated Financial Controls at CBI Conference 2ClearTrial Selected to Provide Methodologies for Accurately Forecasting and Budgeting Clinical Spend and Integrated Financial Controls at CBI Conference 3ClearTrial Selected to Provide Methodologies for Accurately Forecasting and Budgeting Clinical Spend and Integrated Financial Controls at CBI Conference 43SBio and Panacor Bioscience Enter Collaboration and License Agreement to Develop and Commercialize Nephoxil(R) for Hyperphosphatemia 23SBio and Panacor Bioscience Enter Collaboration and License Agreement to Develop and Commercialize Nephoxil(R) for Hyperphosphatemia 33SBio and Panacor Bioscience Enter Collaboration and License Agreement to Develop and Commercialize Nephoxil(R) for Hyperphosphatemia 4... Kingdom,s lead centre for the developing technology to counter ... and Physical Sciences Research Council. , Almost 7m ... and Knowledge Centre - the Centre for Secure Information ... Institute of Electronics, Communications and Information Technology (ECIT) in ...
... VNUS(R) Medical,Technologies, Inc. (Nasdaq: VNUS ), a ... venous reflux disease, today announced its,plans to present at the ... 2008, at The New York Palace Hotel in New York ... Chief Executive,Officer. , VNUS, ...
... ARBOR, Mich., Nov. 21 MichBio, the association ... service providers to its fourth annual Expo on ... Financial ShowPlace in Novi, MI. The MichBio ... industry professionals.,In addition, this year,s event attracted 56 ...
Other Biology Technology:Queen's secures £25M for UK's cyber safety 2MichBio Expo Draws Nearly 500 Professionals; Career Day Raises Profile 2MichBio Expo Draws Nearly 500 Professionals; Career Day Raises Profile 3... at the Case Western Reserve University School of Medicines ... impacting the three billion people exposed to malaria every ... D., and Christopher L. King, M.D., Ph.D. published in ... (PLoS Medicine), novel findings proving new antibodies inhibit infection ...
... times as likely as U.S-born children to suffer from lead ... Department study, and the risk is highest among the most ... poisoning in 2002, published online in the American Journal of ... abroad within the previous six months were 11 times as ...
... -- Two deadly and highly infectious viruses -- both potential ... new drug developed by scientists at Weill Cornell Medical College ... related, newly recognized zoonotic viruses that can spread from their ... pigs, horses and humans. , The mode of transmission ...
Other Biology News:CWRU School of Medicine has evidence vaccine against malaria will reduce disease 2Study shows immigrant children are at increased risk of lead poisoning 2Study shows immigrant children are at increased risk of lead poisoning 3Drug aimed at 2 bioterror agents blocks live viral infection, Weill Cornell team reports 2Drug aimed at 2 bioterror agents blocks live viral infection, Weill Cornell team reports 3... LC Sciences provides a genome-wide microRNA (miRNA) ... proprietary probe design, which enable highly sensitive ... We have standard arrays for mature miRNA ... version of the Sanger miRBase database (Release ...
... studies, vaccine development, and biosensor development ... Paraflo microfluidic on-chip synthesis platform. These ... our comprehensive Epitope Peptide Microarray Service. ... Probe content is completely customer specified. ...
... peptide microarrays designed for quantitative assays ... and built on the flexible and ... of customer specified sequences can be ... provide assistance with custom sequence design. ...
... first time, you can identify and characterize ... without interferences. The Agilent Multiple Affinity Removal ... high-abundant proteins from human serum, plasma, CSF ... device. With this revolutionary system, you can: ...
Biology Products:Biology NavigationMedical Navigation